Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-003608
Filing Date
2017-01-24
Accepted
2017-01-24 16:30:35
Documents
1
Period of Report
2017-01-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v457389_4.html 4  
1 OWNERSHIP DOCUMENT v457389_4.xml 4 5269
  Complete submission text file 0001144204-17-003608.txt   6729
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHARMATHENE, INC., ONE PARK PLACE SUITE 450 ANNAPOLIS MD 21401
Business Address
Runge Jeffrey W. (Reporting) CIK: 0001479091 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 17544058